Cas no for 86811-58-7,Fluazuron ACID Cas number search msds database,online free cas number chemistry search engine,cas number sigma aldrich - PharmaSources.com

Products
Suppliers
Sourcing Requests

Post Sourcing Request Exhibition

Home
Products
Supplier
E-Trade Season
Content Hub
Industry Insights
Service & Membership
For Supplier

My Account

My Online Store

My EZSourcing

View Sourcing Requests

Customer Service
For Buyer

Search Products & Suppliers
Products Directory Suppliers Discovery Post EZSourcing
Service
Buyer Sourcing Event Contact Us
Quick links
My Favorites Recent Visit History

Home > CAS No. Inquiry > 86811-58-7

86811-58-7

[CAS Name] Fluazuron

[Formula] C20H10Cl2F5N3O3

Search Products Post Sourcing Request

Basica Info

[CAS Name]Fluazuron
[Alias]1-[4-chloro-3-(3-chloro-5-trifluoromethyl-2-pyridyloxy)phenyl)-3-(2,6-difluorobenzoyl)urea; N-[(4-chloro-3-{[3-chloro-5-(trifluoromethyl)pyridin-2-yl]oxy}phenyl)carbamoyl]-2,6-difluorobenzamide
[Number]86811-58-7
[EINECS]
[Formula]C20H10Cl2F5N3O3
[Molecular weight]506.2097

86811-58-7 Suppliers

Company

Main Products

Shijiazhuang Yuming Bio-Chemical Co., Ltd.

White solid powder, agricultural chemicals

Send Inquiry

JIANGSU TIANHE PHARMACEUTICAL CO.,LTD.

Please contact us for more details

Send Inquiry

NGL FINECHEM

Fluazuron

Feed Additive

Send Inquiry

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us: About PharmaSources; Terms of Service; Privacy Policy; Event Data Sharing Notice; Intellectual Property; Media Partners

Buy: Search Products; Post Sourcing Requests; Search Suppliers; CAS Search

Sell: Member Application; Advertising; Post Products; EZSourcing

Events: CPHI China; PMEC China; Conferences; Search Events

Help: FAQ; Contact Us; Feedback

Copyright 2006-2025 Shanghai Sinoexpo Informa Markets International Exhibition Co. Ltd (All Rights Reserved) 沪ICP备05034851号-182 沪公网安备31010402010101号
Links：
CCCMHPIE SJGLE.com JJGLE.COM JDGLE.COM XIUGLE.COM DENGGLE.COM HPGLE.COM
Follow Us：
Pharma Sources Insight January 2025

PharmaSources Customer Service